April 19, 2014 11:56 PM ET

Life Sciences Tools and Services

Company Overview of Medicilon/MPI Preclinical Research Shanghai, LLC

Company Overview

Medicilon/MPI Preclinical Research Shanghai, LLC provides preclinical drug discovery and development studies to pharmaceutical and biotechnology companies. It offers toxicology services, including general toxicity, in vitro toxicity screening, toxicokinetics, AMES, and micronucleus test services; ADME/PK services, such as bioanalytical, PK/TK, and metabolism services, as well as in vitro studies; and pharmacodynamics services, which comprise disease and xenograph models. The company was founded in 2007 and is based in Shanghai, China. Medicilon/MPI Preclinical Research Shanghai, LLC is a joint venture of MPI Research, Inc. and Shanghai Medicilon, Inc.

585 Chuanda Road

Pudong New Area

Shanghai,  201200

China

Founded in 2007

Phone:

86 21 3126 8381

Fax:

86 21 3126 8381

Key Executives for Medicilon/MPI Preclinical Research Shanghai, LLC

Chief Executive Officer and Director
Co-Founder and Vice Chairman
Chief Financial Officer and Executive Vice President
President of MPI Research
Executive Vice President of Toxicology Operations
Compensation as of Fiscal Year 2013.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Medicilon/MPI Preclinical Research Shanghai, LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.